Literature DB >> 2227592

Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB.

D J Tinga1, P R Timmer, J Bouma, J G Aalders.   

Abstract

From January 1, 1970, to December 31, 1985, 51 patients with stage IB (FIGO) carcinoma of the cervix with lymph node metastases were treated at the University Hospital, Groningen, The Netherlands. The survival rate was 54% and the average duration of follow-up was 78 months (range 47-132). Important clinical variables for survival were investigated retrospectively: the survival rate in patients with a single lymph node metastasis (with tumor confined to the node itself) (n = 23) appeared to be much better than that of patients with multiple node involvement and/or single nodes with extranodular tumor infiltration (n = 28); survival was 85 and 24%, respectively (P less than 0.001). The same applied to patients with only occult lymph node involvement: the survival rate in patients with occult involvement of the hypogastric, external iliac, or obturator nodes was 87% in 19 patients with a single metastasis and 53% in 15 patients with multiple node involvement (P less than 0.02). The survival rate in 8 patients with adenomatous histological components was 42%. In 42 patients with squamous cell carcinoma, the survival rate was 56%. This difference was not statistically significant. Treatment complications and the effect of treatment on the site of recurrence were investigated.

Entities:  

Mesh:

Year:  1990        PMID: 2227592     DOI: 10.1016/0090-8258(90)90428-n

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG.

Authors:  Daniel L J Thorek; Diane S Abou; Bradley J Beattie; Rachel M Bartlett; Ruimin Huang; Pat B Zanzonico; Jan Grimm
Journal:  J Nucl Med       Date:  2012-08-07       Impact factor: 10.057

3.  Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle.

Authors:  Daniel L J Thorek; David Ulmert; Ndeye-Fatou M Diop; Mihaela E Lupu; Michael G Doran; Ruimin Huang; Diane S Abou; Steven M Larson; Jan Grimm
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

4.  An evaluation of chemotherapy in patients with cancer of the cervix and lymph node metastases.

Authors:  H T Ng; C C Yuan; Y Y Kan; E S Ho; M S Yen; K C Chao
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

5.  Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer.

Authors:  Nicole D Fleming; Michael Frumovitz; Kathleen M Schmeler; Ricardo dos Reis; Mark F Munsell; Patricia J Eifel; Pamela T Soliman; Alpa M Nick; Shannon N Westin; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2014-11-18       Impact factor: 5.482

6.  Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.

Authors:  Dae Woo Lee; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim; Eun Ji Nam; Jae Wook Kim
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

7.  Altered expression of sialyl-Tn, Lewis antigens and carcinoembryonic antigen between primary and metastatic lesions of uterine cervical cancers.

Authors:  H Ogawa; M Inoue; O Tanizawa; M Miyamoto; M Sakurai
Journal:  Histochemistry       Date:  1992-05

8.  Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification.

Authors:  Woo-Young Kim; Suk-Joon Chang; Ki-Hong Chang; Seung-Chul Yoo; Mison Chun; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

9.  Validated limited gene predictor for cervical cancer lymph node metastases.

Authors:  Joshua D Bloomstein; Rie von Eyben; Andy Chan; Erinn B Rankin; Daniel R Fregoso; Jing Wang-Chiang; Lisa Lee; Liang-Xi Xie; Shannon MacLaughlan David; Henning Stehr; Mohammad S Esfahani; Amato J Giaccia; Elizabeth A Kidd
Journal:  Oncotarget       Date:  2020-06-16

10.  Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.

Authors:  Jin Hwa Hong; Kyung Jin Min; Jae Kwan Lee; Kyeong A So; Un Suk Jung; Sungeun Kim; Jae Seon Eo
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.